Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for hepatorenal syndrome in Japanese participants
jRCT2051250072Suspended
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Aug 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in hepatorenal syndrome (HRS) comparing Terlipressin arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Aug 2025; status: suspended.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome (HRS)
Beyond the preview
Go deeper on jRCT2051250072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250072.